Clinical Trials Logo

Clinical Trial Summary

Many studies have attempted to find the predictors of adverse neonatal outcome in women with Intrahepatic Cholestasis of Pregnancy(ICP).Serum total bile acid level exceeding 40 µmol/L has been associated with increased risk of meconium staining, low Apgar scores, preterm delivery, and stillbirth.Other predictors such as level of transaminases, history of cholelithiasis, and hepatitis virus infection have been studied but the results are inconclusive.A more comprehensive investigation involving multiple neonatal outcomes and a wide variety of outcome predictors is needed in order to establish guidelines for optimal timing of delivery in pregnancies complicated by ICP. The aim of our study was to evaluate wide variety of predictors of adverse neonatal outcomes in a large cohort of women with ICP .


Clinical Trial Description

We performed a retrospective cohort study of all women diagnosed with ICP. Pregnancy outcomes including delivery gestational age, spontaneous preterm delivery, iatrogenic preterm delivery, birth weight, mode of delivery, oligohydramnios, intrauterine growth restriction (IUGR), placental abruption, preterm premature rupture of membrane (PPROM), concerning fetal heart tracing, chorioamnionitis, endometritis, postpartum hemorrhage, transfusion, stillbirth, neonatal intensive care unit (NICU) admission, hyperbilirubinemia, meconium stained amniotic fluid, respiratory distress syndrome(RDS) or transient tachypnea of newborn(TTN) (transient tachypnea of the newborn), and composite neonatal outcome were ascertained. A composite adverse neonatal outcome was created and defined as any of the following: NICU admission, hypoglycemia, hyperbilirubinemia, RDS, TTN, mechanical ventilation use, oxygen by nasal cannula, pneumonia, and stillbirth. PPROM was defined by rupture of membrane before 37 weeks gestation. Concerning fetal heart tracing was defined as recurrent variable or late decelerations with moderate variability, prolonged decelerations, or category 3 tracing. Providers who were caring for the women reviewed and independently characterized fetal heart tracings. Since fetal heart tracings were not accessible to authors, authors accepted the providers' interpretation. For analysis of concerning fetal heart tracing, women with non-labor cesarean section were excluded. Hyperbilirubinemia was defined by neonatal hyperbilirubinemia that required phototherapy. Hypoglycemia was defined by neonatal hypoglycemia that required intravenous infusion. Diagnosis of RDS and TTN were made by the managing neonatologist and based on standard clinical guidelines. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04922580
Study type Observational
Source Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Contact
Status Completed
Phase
Start date January 1, 2012
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05773677 - Diet in Twin Pregnancy: the Wellness of Mother and Babies. N/A
Completed NCT01499524 - The Metabolic Profile in Intrahepatic Cholestasis of Pregnancy and Diabetes Mellitus
Not yet recruiting NCT01226823 - Ursodeoxycholic Acid And Cholestasis Of Pregnancy Phase 3
Recruiting NCT03834285 - Liver Disease in Pregnancy
Recruiting NCT02480478 - Serum Autotaxin Levels in Cholestasis of Pregnancy N/A
Not yet recruiting NCT04890886 - Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women With Metabolic Diseases
Recruiting NCT01898832 - Il-17 Levels in Intrahepatic Cholestasis of Pregnancy N/A
Recruiting NCT01906827 - P-wave Duration and Dispersion in Intrahepatic Cholestasis of Pregnancy N/A
Completed NCT00700232 - ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls N/A
Terminated NCT04718961 - A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA) Phase 2
Recruiting NCT03519399 - Bile Acid Effects in Fetal Arrhythmia Study
Completed NCT05151913 - The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
Recruiting NCT05691036 - Bile Acids Metabolism and Genetic Mutation Profile in the ICP in the Indian Population
Withdrawn NCT01965054 - The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy N/A
Recruiting NCT05637151 - Different Effects of Delayed Clamping on Neonatal Bilirubin Levels Between Pregnant Women With Intrahepatic Cholestasis of Pregnancy and Normal Pregnant Women N/A
Not yet recruiting NCT06366659 - Unraveling the Pathogenesis of Pruritus in Intrahepatic Cholestasis of Pregnancy
Not yet recruiting NCT06364969 - Investigation of the Pruritogens of Liver-related Diseases